Abstract

Objective To screen and prepare a broad-spectrum monoclonal antibody against Streptococcus pneumoniae (S.pneumoniae) surface protein A (PspA) and to evaluate its potential in clinical practice. Methods Hybridoma cells were screened and inoculated into the abdominal cavities of BALB/c mice to prepare antibodies in ascites. Monoclonal antibodies were obtained by ammonium sulfate precipitation and protein A affinity chromatography and then identified by SDS-PAGE and Western blot. Their specificity, isoforms and killing activities in vitro were analyzed. Results A broad-spectrum monoclonal antibody that recognized PspA subclasses 2, 3 and 4 was obtained. Its in vitro killing rate against S. pneumoniae reached 40.3%. Conclusions A broad-spectrum monoclonal antibody that could specifically bind to PspA was successfully prepared with a strong in vitro killing activity. This study provided reference for clinical diagnosis of S. pneumoniae-related diseases, quality assessment of S. pneumoniae vaccines and further research on monoclonal antibody therapeutics. Key words: Streptococcus pneumoniae; Streptococcus pneumoniae surface protein A (PspA); Monoclonal antibody

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.